Literature DB >> 15703314

Systemic collateral supply in patients with chronic thromboembolic and primary pulmonary hypertension: assessment with multi-detector row helical CT angiography.

Martine Remy-Jardin1, Alain Duhamel, Valérie Deken, Nébil Bouaziz, Philippe Dumont, Jacques Remy.   

Abstract

PURPOSE: To compare retrospectively the frequency of systemic collateral supply in patients who have chronic thromboembolic pulmonary hypertension with the frequency of systemic collateral supply in patients who have primary pulmonary hypertension by using multi-detector row helical computed tomographic (CT) angiography.
MATERIALS AND METHODS: For this review, neither institutional board approval nor informed consent was required. Thirty-six consecutive patients, including 22 patients (four men, 18 women; mean age, 46.0 years) with chronic thromboembolic pulmonary hypertension (group 1) and 14 patients (five men, nine women; mean age, 63.0 years) with primary pulmonary hypertension (group 2), underwent multisection spiral CT angiography of the pulmonary and systemic circulations with a four- (n = 17) or 16- (n = 19) detector row scanner. CT angiograms were assessed for the presence of abnormal bronchial and/or nonbronchial systemic arteries, CT features of pulmonary hypertension, and right ventricular dysfunction. Vascular and parenchymal signs of chronic pulmonary embolism were specifically analyzed on CT angiograms of group 1 patients. Comparative analyses were performed by using the chi(2) or the Fisher exact test for categoric data. An unpaired bilateral Wilcoxon rank sum test was used for continuous data. A chi(2) goodness-of-fit test was used to compare observed proportions with equal proportions.
RESULTS: The degree of pulmonary hypertension was comparable in groups 1 and 2. Abnormally enlarged systemic arteries were identified in 16 (73%) of 22 patients from group 1 and in two (14%) of 14 patients from group 2 (P = .002). The systemic collateral supply in group 1 comprised enlargement of both bronchial and nonbronchial systemic arteries in nine (56%) of the 16 patients; the remaining seven patients had an exclusive enlargement of bronchial systemic arteries (n = 6, 38%) or nonbronchial (n = 1, 6%) systemic arteries. A total of 31 enlarged nonbronchial systemic arteries were depicted, including 13 inferior phrenic arteries, 10 intercostal arteries, seven internal mammary arteries, and one lateral thoracic artery. The mean +/- standard deviation of abnormal nonbronchial systemic arteries per patient was 1.4 +/- 1.9. No relationship was found between the mean number of abnormally enlarged nonbronchial systemic arteries and the CT angiographic features of chronic pulmonary embolism.
CONCLUSION: These results demonstrate the higher frequency of abnormally enlarged bronchial and nonbronchial systemic arteries in patients who have chronic thromboembolic pulmonary hypertension compared with patients who have primary pulmonary hypertension; this finding could help distinguish these two entities on CT angiograms. (c) RSNA, 2005.

Entities:  

Mesh:

Year:  2005        PMID: 15703314     DOI: 10.1148/radiol.2351040335

Source DB:  PubMed          Journal:  Radiology        ISSN: 0033-8419            Impact factor:   11.105


  32 in total

Review 1.  Rare causes of pulmonary hypertension: spectrum of radiological findings and review of the literature.

Authors:  Alice Rossi; Maurizio Zompatori; Patrick Tchouante Tchouanhou; Michele Amadori; Massimiliano Palazzini; Elisa Conficoni; Nazzareno Galiè; Venerino Poletti; Giampaolo Gavelli
Journal:  Radiol Med       Date:  2013-11-15       Impact factor: 3.469

Review 2.  Imaging of Chronic Thromboembolic Disease.

Authors:  Adina Haramati; Linda B Haramati
Journal:  Lung       Date:  2020-03-12       Impact factor: 2.584

3.  Prevalence of coronary artery-pulmonary artery collaterals in patients with chronic thromboembolic pulmonary hypertension.

Authors:  Noel S Lee; Daniel G Blanchard; Kirk U Knowlton; Anna M McDivit; Victor Pretorius; Michael M Madani; Peter F Fedullo; Kim M Kerr; Nick H Kim; David S Poch; William R Auger; Lori B Daniels
Journal:  Pulm Circ       Date:  2015-06       Impact factor: 3.017

4.  Hemoptysis requiring bronchial artery embolization in pulmonary arterial hypertension.

Authors:  Jose A Cantu; Zeenat Safdar
Journal:  South Med J       Date:  2010-09       Impact factor: 0.954

Review 5.  Chronic thromboembolic pulmonary hypertension - assessment by magnetic resonance imaging.

Authors:  Karl-Friedrich Kreitner; R Peter Kunz; Sebastian Ley; Katja Oberholzer; Daniel Neeb; Klaus K Gast; Claus-Peter Heussel; Balthasar Eberle; Eckhard Mayer; Hans-Ulrich Kauczor; Christoph Düber
Journal:  Eur Radiol       Date:  2006-07-13       Impact factor: 5.315

6.  Comparative clinical and predictive value of lung perfusion blood volume CT, lung perfusion SPECT and catheter pulmonary angiography images in patients with chronic thromboembolic pulmonary hypertension before and after balloon pulmonary angioplasty.

Authors:  Hirofumi Koike; Eijun Sueyoshi; Ichiro Sakamoto; Masataka Uetani; Tomoo Nakata; Kouji Maemura
Journal:  Eur Radiol       Date:  2018-05-25       Impact factor: 5.315

Review 7.  Chronic pulmonary embolism: diagnosis.

Authors:  Katia Hidemi Nishiyama; Sachin S Saboo; Yuki Tanabe; Dany Jasinowodolinski; Michael J Landay; Fernando Uliana Kay
Journal:  Cardiovasc Diagn Ther       Date:  2018-06

8.  Angiogenesis in the ischemic rat lung.

Authors:  John Jenkins; Elizabeth Wagner
Journal:  J Vis Exp       Date:  2013-02-08       Impact factor: 1.355

9.  Impact of CT perfusion imaging on the assessment of peripheral chronic pulmonary thromboembolism: clinical experience in 62 patients.

Authors:  Julien Le Faivre; Alain Duhamel; Suonita Khung; Jean-Baptiste Faivre; Nicolas Lamblin; Jacques Remy; Martine Remy-Jardin
Journal:  Eur Radiol       Date:  2016-03-14       Impact factor: 5.315

10.  Right-to-left shunt with hypoxemia in pulmonary hypertension.

Authors:  Jean-Frédéric Vodoz; Vincent Cottin; Jean-Charles Glérant; Geneviève Derumeaux; Chahéra Khouatra; Anne-Sophie Blanchet; Bénédicte Mastroïanni; Jean-Yves Bayle; Jean-François Mornex; Jean-François Cordier
Journal:  BMC Cardiovasc Disord       Date:  2009-03-31       Impact factor: 2.298

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.